During the last session, Ocean Biomedical Inc (NASDAQ:OCEA)’s traded shares were 67.33 million, with the beta value of the company hitting 1.30. At the end of the trading day, the stock’s price was $0.17, reflecting an intraday loss of -13.10% or -$0.03. The 52-week high for the OCEA share is $7.79, that puts it down -4482.35 from that peak though still a striking 35.29% gain since the share price plummeted to a 52-week low of $0.11. The company’s market capitalization is $6.06M, and the average intraday trading volume over the past 10 days was 143.01 million shares, and the average trade volume was 23.69 million shares over the past three months.

Ocean Biomedical Inc (NASDAQ:OCEA) trade information

Ocean Biomedical Inc (OCEA) registered a -13.10% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -13.10% in intraday trading to $0.17, hitting a weekly high. The stock’s 5-day price performance is 19.12%, and it has moved by -74.58% in 30 days. Based on these gigs, the overall price performance for the year is -68.40%. The short interest in Ocean Biomedical Inc (NASDAQ:OCEA) is 0.17 million shares and it means that shorts have 2.64 day(s) to cover.

OCEA Dividends

Ocean Biomedical Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Ocean Biomedical Inc (OCEA) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 243.67 shares. This amounts to just over 0.70 percent of the company’s overall shares, with a $42350.0 market value. The same data shows that the other fund manager holds slightly less at 156.2, or about 0.45% of the stock, which is worth about $27147.0.